Organization
Orion Pharma
4 clinical trials
Clinical trial
Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate CancerStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Safety and Pharmacokinetics of ODM-209 in Patients With Metastatic Castration-resistant Prostate Cancer or Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast CancerStatus: Completed, Estimated PCD: 2024-01-09
Clinical trial
Use of Buventol Easyhaler and Bufomix Easyhaler as Relievers in Methacholine Challenge Testing and Inspiratory Flow Profiles During Induced Bronchoconstriction in Adult SubjectsStatus: Completed, Estimated PCD: 2023-06-30
Clinical trial
Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS: Open-Label Extension for Patients Completing Study 3119002Status: Terminated, Estimated PCD: 2020-11-18